Can a hope program lift spirits during lung cancer treatment?

NCT ID NCT06047301

Recruiting now Symptom relief Sponsor: Laurie McLouth Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a brief program called Pathways, designed to help people with advanced lung cancer set personal goals and improve their mental health and quality of life during treatment. About 234 participants will be randomly assigned to receive either the Pathways program or enhanced usual care. Researchers will measure changes in depression, hope, and anxiety over several weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pathways hope-based behavioral intervention
What this could lead to: If it works, this could provide a simple, supportive program to help advanced lung cancer patients feel less depressed and more hopeful during treatment.
What could go wrong: This is an early-stage behavioral study with no blinding, so results may be influenced by placebo effects or participant expectations. The intervention is brief and may not produce lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

University of Kentucky
RECRUITING

Lexington, Kentucky, 40506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.